logotype

Category: TRUVIEW

header-blog-post

Otitis Cytology in Dogs: A Vet’s Guide to Ear Cytology Interpretation 

Otitis externa is one of the most common reasons dogs and cats end up in the exam room, and it rarely resolves with a single visit. A VetCompass study of dogs under UK primary veterinary care found a one-year period prevalence of 7.30% across a random sample of more than 22,000 dogs, with breed and ear carriage ranking as the highest risk factors. Feline cases occur at a lower but still clinically meaningful rate. 

Otitis cytology in dogs is what turns that exam room presentation into a treatment decision. Getting the diagnosis right the first time depends on it, but staining variability and turnaround time can slow the workflow down at exactly the moment a clear answer matters most. 

This post breaks down how to interpret ear cytology findings, how to tell Malassezia from cocci on the slide, what is actually driving diagnostic inconsistency between clinics, and how faster, more standardized slide prep is changing that workflow for practices that see these cases every week. 

Why Cytology Is the Standard for Otitis Externa Diagnosis 

Otitis externa is a multifactorial disease. Effective, lasting treatment depends on separating primary causes (like allergies or parasites) from secondary infections and the perpetuating factors that keep an ear from healing even after the underlying cause is addressed, a framework outlined in the Journal of the American Veterinary Medical Association’s review on managing recurrent otitis externa. 

Bacterial culture is sometimes used to guide therapy, but it has real limitations in the ear. A 2022 study published in Veterinary Sciences compared cytology, bacterial culture, and 16S amplicon profiling in dogs with chronic suppurative otitis externa and found only moderate agreement between cytology and culture results, around 60% of samples. The same study noted that over a third of the bacterial species detected through DNA sequencing at meaningful abundance levels were missed by culture entirely. Culture and susceptibility panels are also built around blood-level drug concentrations, which do not reflect the much higher concentrations achieved with topical therapy, one reason many dermatologists rely on cytology as the primary diagnostic and monitoring tool rather than defaulting to culture. 

Cytology, by contrast, gives an immediate read on what is actually present on the slide: cocci, rods, yeast, and the inflammatory response driving clinical signs. That immediacy is exactly why the Merck Veterinary Manual lists cytological evaluation, alongside history and otoscopic exam, as a core part of otitis externa diagnosis, and why it should be performed at the initial visit and at every recheck, not just when a case looks complicated. Accurate ear cytology interpretation at each of those visits is what actually drives the treatment decision, not the culture result that may take days to come back. 

Ear Cytology Interpretation: What You Are Looking For on the Slide 

A useful ear cytology read typically covers a few key findings: 

What you see 

What it suggests 

Clinical takeaway 

Cocci 

Often Staphylococcus species 

Usually more straightforward to resolve with topical therapy 

Rods 

Commonly Pseudomonas or other gram-negatives 

Signals a more complicated case; may need a different treatment approach and closer monitoring 

Yeast (Malassezia) 

Frequent contributor in both dogs and cats 

Shapes topical therapy choice; often present alongside bacteria, so a slide is not fully read until both are accounted for 

Neutrophils (especially degenerated) 

Active bacterial process 

Higher counts support more aggressive treatment 

Few to no inflammatory cells 

Case may be resolving, or not truly infectious 

Worth considering allergic otitis rather than infection 

Intracellular organisms 

More established, significant infection 

May warrant more aggressive treatment than extracellular organisms alone 

Organism density (few vs. sheets) 

Distinguishes early/resolving cases from active infection 

Density, not just presence, helps determine whether topical therapy is still needed 

 

When rods dominate the slide, the stakes go up since these organisms are often associated with greater antimicrobial resistance concerns. A retrospective analysis of bacterial isolates from dogs with pyoderma and otitis externa found that while Staphylococcus species, particularly S. pseudintermedius, were the most common isolates, Pseudomonas and Proteus were also frequently identified, and multidrug resistance was a recurring finding. The authors recommend prioritizing topical therapy and reserving systemic antibiotics for exceptional cases after susceptibility testing, which is another argument for cytology as the tool that guides the topical plan. 

What Counts as an Otitis Externa Cytology Positive 

This is where practices diverge more than most clinicians realize. There is no single agreed threshold for calling an ear cytology positive. Commonly cited cutoffs for yeast and bacteria per high-power field vary between references and between individual dermatologists, and none of them are universally adopted. 

That means the call often comes down to the reader’s judgment of density, morphology, and the inflammatory picture, applied to whatever the slide happens to look like. Which makes slide quality the variable that quietly decides borderline cases. 

None of this is useful if the sample itself is inconsistent. A comparative study of two ear cytology collection methods in dogs with otitis externa found that a cotton-tipped swab technique and a deep-canal aspiration technique produced different yields of neutrophils, a reminder that consistent sampling matters just as much as consistent interpretation. A well-collected sample that then sits on an inconsistently stained slide still leaves room for two clinicians to read the same ear differently. found that a cotton-tipped swab technique and a deep-canal aspiration technique produced different yields of bacteria, yeast, and inflammatory cells, a reminder that consistent sampling matters just as much as consistent interpretation. A well-collected sample that then sits on an inconsistently stained slide still leaves room for two clinicians to read the same ear differently. 

 

Produced statistically different yields of neutrophils, a reminder that  

Malassezia vs. Cocci on Ear Cytology: Telling Them Apart and Why It Changes Treatment 

The single most common read in ear cytology is distinguishing yeast from bacteria, and most slides contain both. 

Malassezia are unmistakable once you have seen a few. They are roughly 3 to 8 micrometers, several times the size of a coccus, and shaped like a peanut, a snowman, or a bowling pin depending on which textbook you learned from. That shape comes from broad-based unipolar budding, where the daughter cell separates from one pole without pinching off into a neat sphere. They take up Romanowsky stain readily and appear deep blue to purple. The ACVD clinical consensus guidelines on the biology, diagnosis, and treatment of Malassezia dermatitis in dogs and cats are the references worth keeping on hand for anything beyond identification. 

Cocci are round, roughly one micrometer, and typically appear in pairs, tetrads, or grape-like clusters. At 100x oil they read as fine purple dots against the background, and the size difference next to a Malassezia organism is dramatic enough that the two are rarely confused once both are on the same slide. 

The trouble is what mimics them. Melanin granules, keratin debris, and stain precipitate all produce small dark specks that can pass for cocci to a tired eye at the end of a long day. Stain precipitate in particular tends to show up when reagents are aging or dip times drift, which means the artifact most likely to be misread as bacteria is generated by the same staining inconsistency described in the next section. 

Why the distinction drives treatment: yeast and bacteria require different active ingredients in the topical. A slide read as yeast-only leads to an antifungal-weighted product, a bacteria-only read leads to an antibacterial one, and the mixed infections that make up a large share of otitis cases need both addressed. Treating only the organism that jumped out first is one of the more common reasons an ear improves partially and then stalls. 

Why Ear Cytology Results Vary Between Techs 

Even with good sampling, staining and slide prep introduce variability that has nothing to do with a clinician’s skill. Manual Romanowsky staining involves several timed dip steps, and small differences in dip time, reagent freshness, or how a slide is dried can all change how the same sample looks under the microscope. Two technicians staining the same sample, on the same day, can produce slides that look meaningfully different, which can shift how a borderline case gets read and treated, especially when organism counts are close to a threshold that determines whether a case is called infected or not. 

That inconsistency is a systemic issue built into manual staining workflows, not a reflection of individual technique or effort. It shows up most in high-volume practices, where the same tech may be staining dozens of slides a day, and in multi-doctor practices, where different clinicians may be reading slides prepared by different team members. It is also one of the harder problems to catch, since an inconsistent slide does not announce itself. It just quietly nudges a borderline read one way or the other, and the vet interpreting it usually has no way to know which one they are looking at. 

This is the gap that standardized, automated slide processing is designed to close. 

In-House Ear Cytology vs. Send-Out: What You Gain and What You Give Up 

Most practices are performing ear cytology in-house, but here are some factors to consider. 

Send-out gets you a board-certified clinical pathologist reading the slide, which is genuinely valuable for ambiguous cases, suspected neoplasia, or anything that does not fit the usual otitis picture. What it costs you is time. The traditional workflow runs prepare, package, ship, wait, review, receive report, and the ear cytology turnaround time on that sequence is typically measured in days. For a patient who is painful and an owner who wants an answer before they leave, that gap is the whole problem. 

In-house ear cytology collapses that timeline to the length of the appointment. The vet sees the slide, makes the call, and dispenses the medication topical before the client walks out. What you give up is the specialist read and, in a manual staining workflow, the consistency that a dedicated lab brings to slide prep. 

For most otitis cases the clinical question is straightforward enough that in-house wins on speed without giving up much accuracy. The cases where send-out earns its turnaround are the ones that do not look like routine otitis in the first place. The practical answer for a lot of practices is not choosing between them, but having a workflow where the routine cases resolve in-house and the unusual ones escalate to a pathologist without restarting the sample collection process. 

How the TRUVIEW® AI Microscope Speeds Up Ear Cytology Confirmation 

The TRUVIEW® AI microscope replaces the manual, timed-dip staining process with TRUprep® automated slide preparation. Insert the slide, and the system smears, stains, washes, dries, and digitizes it on a fixed cycle, so stain exposure, reagent volume, and drying are identical on every slide regardless of who is running the sample or how busy the clinic is that day. Instead of a tech eyeballing dip counts between appointments, every slide goes through the same standardized steps, which removes the tech-to-tech and day-to-day variability described above from the read itself. 

For ear cases specifically, the Ear Cytology Quick Scan protocol streamlines slide prep and scanning so a slide that might otherwise sit in a queue behind other cases is imaged and ready to read in minutes. For a practice running multiple otitis cases in a single day, that difference in speed adds up: same-visit answers instead of asking an owner to wait for a callback, and less time between sample collection and a treatment decision. 

The TRUVIEW system also captures and stores a digital image of every slide, which solves a second problem manual cytology does not: there is no permanent record of what the tech or vet actually saw under the scope at the time. A stored image can be pulled back up at a recheck, compared side by side with the current slide, or shared with a referring vet or a board-certified pathologist through the myZomedica® portal without needing to physically send a slide. That is a meaningful upgrade over a written note that says “moderate cocci, few WBCs” with no way to verify it later. 

That telepathology connection is also what makes the in-house vs. send-out tradeoff less of a tradeoff. Routine cases resolve during the appointment, and the unusual ones go to a pathologist from the same digitized slide, without recollecting a sample or shipping anything. 

To be clear on scope: the TRUVIEW microscope supports and speeds up cytology-based confirmation. The veterinarian is still the one interpreting the slide and making the diagnosis. The platform’s role is removing the staining variability and turnaround-time bottleneck from that process, not replacing clinical judgment. 

Ready to see how the TRUVIEW microscope’s ear cytology workflow fits into your practice? Request a demo! 

Chronic Ear Infection in Dogs: Why Cytology Consistency Matters Most Here 

Chronic otitis is where repeatable cytology matters most. Rechecks are common in these cases, since resolving the underlying cause often takes multiple rounds of treatment adjustment, and each recheck depends on an accurate read to know whether the current plan is working. 

Working up a chronic ear infection in a dog means cytology is only part of the picture. Allergic disease is the most common primary cause, and the 2023 AAHA Management of Allergic Skin Diseases in Dogs and Cats Guidelines lay out the workup for allergic otitis externa alongside the rest of the minimum dermatologic database. Endocrine disease is another recurring culprit, and the TRUFORMA® diagnostic platform runs the thyroid and adrenal assays that help diagnose at the point of care. 

This is also where inconsistent staining does the most damage. If a slide from the first visit was read as heavily infected and a recheck slide two weeks later reads as only mildly infected, is that real improvement or a difference in how the two slides were stained? Without standardization, that question is hard to answer with confidence, and it is exactly the kind of ambiguity that can lead to a treatment plan being extended, changed, or stopped based on noise rather than signal. 

A fast, standardized cytology read at each recheck makes it easier to track whether an ear is actually improving or whether the treatment plan needs to change, without adding another 24-hour turnaround to a case that is already dragging on for the owner and the patient. 

Frequently Asked Questions About Ear Cytology in Dogs 

How many yeast per HPF is abnormal on ear cytology? 

There is no universally agreed threshold, which is part of why slide-to-slide consistency matters so much. Commonly cited references suggest that more than 5 to 10 Malassezia organisms per high-power field (HPF) at 400x is considered significant, but individual dermatologists vary, and clinical signs should always factor into the interpretation. A high yeast count in an asymptomatic ear reads differently than the same count in a dog that has been scratching for weeks. 

What does a normal ear cytology look like? 

A cytology from a healthy ear typically shows low numbers of Malassezia (fewer than 5 per HPF), no bacteria, and little to no inflammatory response. Small amounts of ceruminous debris and occasional epithelial cells are expected. The absence of cocci, rods, and neutrophils is what distinguishes a normal slide from an early or resolving infection. 

How often should you recheck ear cytology? 

For active infections, a recheck cytology at two to three weeks is standard practice to confirm the infection is responding to treatment. For chronic or recurrent cases, cytology at every recheck visit is warranted regardless of how the ear looks clinically, since a slide that appears improved visually does not always match what is happening at the cellular level. Persistent organisms or a shift in organism type (cocci to rods, for example) between visits is clinically significant information that a visual exam alone will miss. 

The Bottom Line 

A quick recap for the slide in front of you: 

  • Rods, high organism density, or intracellular bacteria mean a more complicated case. Treat and monitor closely. 
  • No improvement between visits means questioning whether it is the treatment or the read before extending or switching therapy. 
  • Yeast and bacteria together means both need to be addressed in the treatment plan, not just the more obvious one. 
  • Sparse findings with ongoing signs means considering allergic otitis rather than infection. 

Otitis is one of the most common problems in small animal practice. While it is often a one-visit diagnosis, it is rarely a condition that requires just one vet visit. Getting cytology interpretation right, consistently and quickly, is not just a diagnostic nicety. It is central to getting these patients comfortable faster, giving owners a clear answer sooner, and keeping cases from cycling back through the exam room unresolved. 

© 2026 Zomedica Inc. All rights reserved. TRUVIEW is a registered trademark of Zomedica Inc. 

Blog Banner for Website Content (14)

Veterinary Cardiac Testing: Advanced Heart Disease Diagnostics Equipment

Based on clinical insights from Dr. Gary Oswald’s webinar, When the Heart Cries for Help. Using NT-proBNP in Canine Cardiac Disease*

Heart disease affects millions of dogs and cats, yet most cases go undetected until patients present in crisis. Studies show that many cardiac conditions remain hidden for months or years before becoming clinically apparent, often making their first appearance as sudden death or acute heart failure. The TRUFORMA® diagnostic system revolutionizes veterinary cardiac care by bringing advanced heart disease testing directly into general practice, enabling early detection and better patient outcomes through rapid NT-proBNP cardiac biomarker analysis. 

The Hidden Epidemic: Heart Disease in Veterinary Practice

Heart disease represents one of the most challenging diagnostic areas for general practitioners, with traditional methods often failing until disease reaches advanced stages. 

Common Diagnostic Challenges: 

  • Physical examination may appear normal in early disease stages 
  • Heart murmurs can be absent in many cardiomyopathy cases 
  • Chest radiographs often show no changes until heart failure develops 
  • ECG abnormalities frequently absent in subclinical patients 
  • Patient stress during examination masks subtle signs 

Clinical Reality: Many pets with significant heart disease show no obvious symptoms during routine wellness visits, leaving veterinarians without clear indicators to pursue cardiac evaluation. 

The Cost of Late Detection

Patient Impact: 

  • First symptom often sudden death or acute heart failure 
  • Advanced disease requires more aggressive, expensive treatment 
  • Shorter lifespan and reduced quality of life 
  • Limited treatment options once heart failure develops 

Practice Impact: 

  • Emergency presentations requiring immediate referral 
  • Client dissatisfaction when disease “appears suddenly” 
  • Missed opportunities for preventive care 
  • Higher liability risk from undiagnosed conditions 

How to Diagnose Heart Disease in Dogs and Cats

Subtle Symptoms Pet Owners Report: 

  • Exercise intolerance or tiring more easily during walks 
  • Heavy breathing during normal activities 
  • Restlessness at night or difficulty settling 
  • Coughing episodes especially at night or early morning 
  • Decreased appetite or reluctance to eat 
  • Weight loss despite normal eating habits 

Clinical Signs for Veterinarians: 

  • Soft heart murmurs that may be intermittent 
  • Increased respiratory effort during examination 
  • Pale or slow capillary refill indicating poor circulation 
  • Weak pulses or pulse deficits 
  • Behavioral changes such as hiding or decreased activity 

Traditional Diagnostic Limitations

Physical Examination Challenges: While cardiac auscultation remains important, many patients with significant heart disease present with normal or only subtle examination findings, particularly cats with cardiomyopathies and dogs with early dilated cardiomyopathy. 

Radiographic Limitations: Chest X-rays frequently appear normal in subclinical cardiac patients. Even when abnormalities are present, distinguishing cardiac from respiratory causes can be challenging, especially in emergency situations. 

The Diagnostic Gap: General practitioners need reliable tools to identify cardiac disease before clinical signs develop, allowing for early intervention and improved patient outcomes. 

Advanced Heart Disease Testing: The NT-proBNP Solution

NT-proBNP (N-terminal pro-B-type natriuretic peptide) serves as the heart’s “cry for help,” providing objective evidence of cardiac stress when traditional diagnostic methods fall short. 

How Cardiac Biomarkers Work: When the heart experiences stress from increased pressure or volume, cardiac cells produce a hormone called pro-BNP. This molecule is then split into two parts: 

  • Active BNP: Helps the body manage cardiac stress by promoting blood vessel dilation and kidney function 
  • NT-proBNP: Inactive fragment that remains in the bloodstream longer and can be easily measured 

Clinical Advantage: NT-proBNP levels rise significantly before clinical signs appear, enabling early detection of heart disease in apparently healthy patients. 

Why NT-proBNP Testing Transforms General Practice

Immediate Clinical Applications: 

  • Emergency triage of patients with breathing difficulties 
  • Pre-anesthetic screening for high-risk patients 
  • Wellness screening in breeds prone to heart disease 
  • Treatment monitoring for patients with known cardiac conditions 

Practice Benefits: 

  • 15-minute results for immediate clinical decision-making 
  • Objective data to support clinical findings 
  • Client confidence in advanced diagnostic capabilities 
  • Early intervention opportunities improving patient outcomes 

Signs of Heart Failure in Pets: When to Test

Dogs Presenting with Breathing Difficulties: Emergency differentiation between heart and lung problems is critical for appropriate treatment. Traditional methods often leave uncertainty in diagnosis. 

Common Emergency Presentations: 

  • Labored breathing with or without coughing 
  • Exercise intolerance or collapse during activity 
  • Loud heart murmurs in breeds not typically affected 
  • Distended abdomen potentially indicating heart failure 
  • Anxiety or restlessness especially at night 

NT-proBNP Reference Values for Dogs: 

  • Below 900 pmol/L: Respiratory cause likely, heart failure unlikely 
  • Above 2500 pmol/L: Congestive heart failure probable 
  • 900-2500 pmol/L: Consider pulmonary hypertension, pursue cardiac evaluation 

Cat Heart Problems: Silent Disease Detection

Feline Cardiac Disease Challenges: Cats excel at hiding cardiac disease, often showing no symptoms until presenting in acute heart failure or sudden death. 

When to Suspect Feline Heart Disease: 

  • Any heart murmur detected during examination 
  • Breathing difficulties or open-mouth breathing 
  • Sudden onset of rear limb paralysis 
  • Hiding behavior or decreased activity 
  • Poor appetite or weight loss 

NT-proBNP Reference Values for Cats: 

  • Below 100 pmol/L: Heart disease unlikely 
  • Above 300 pmol/L: Significant cardiac disease probable 
  • Special consideration: All cats with heart murmurs should receive NT-proBNP testing 

TRUFORMA® Diagnostic System: Revolutionary Point-of-Care Testing

The TRUFORMA diagnostic system brings laboratory-quality cardiac testing directly into veterinary clinics, providing rapid, accurate results that guide immediate treatment decisions. 

Key Technology Features: 

  • Bulk acoustic wave technology eliminates interference from hemolysis or lipemia 
  • 15-20 minute results for immediate clinical decision-making 
  • Self-contained cartridges require no reagent preparation 
  • Multiple test capabilities beyond cardiac biomarkers 

Clinical Advantages: 

  • Sample flexibility: Works with both plasma and serum 
  • Minimal training required for operation 
  • Compact design fits in any clinic setting 
  • Proven accuracy with correlation >0.95 to reference laboratories 

TRUFORMA System vs. Send-Out Testing

Breed-Specific Cardiac Screening Guidelines

High-Risk Canine Breeds 

Dilated Cardiomyopathy-Prone Breeds: 

  • Doberman Pinschers: Special consideration with lower threshold (700 pmol/L) 
  • Great Danes: Standard screening protocols 
  • Irish Wolfhounds: Annual screening recommended 
  • Standard Schnauzers: Begin screening at 4-5 years 
  • Boxers: Monitor for both DCM and arrhythmogenic cardiomyopathy 

Breed-Specific Considerations: Labrador Retrievers, Newfoundlands, Greyhounds: May have elevated NT-proBNP values (>900 pmol/L) even with normal hearts. Pursue cardiac evaluation but normal echo findings are not uncommon in these breeds. 

High-Risk Feline Breeds 

Hypertrophic Cardiomyopathy-Prone Breeds: 

  • Maine Coons: Begin screening at 2-3 years 
  • Ragdolls: Annual testing recommended 
  • Sphynx cats: High predisposition requires early screening 
  • British Shorthairs: Include in routine wellness protocols 
  • Persians: Consider screening all breeding animals 

Universal Feline Screening: Given the difficulty in detecting feline heart disease through examination alone, many specialists recommend annual NT-proBNP screening for all adult cats as part of routine wellness care. 

TRUFORMA

Ready to Transform Your Heart Disease Detection?

Don’t let cardiac disease hide in your patients until emergency situations develop. Implement advanced cardiac testing to provide early detection, accurate emergency triage, and comprehensive patient management throughout the disease process. 

Visit zomedicadev.com to explore the TRUFORMA diagnostic system’s cardiac testing capabilities and discover how advanced heart disease detection can enhance your practice’s patient care standards while improving diagnostic confidence and practice profitability. 

© 2025 Zomedica, Inc. All rights reserved. 

*Dr. Oswald was paid by Zomedica, Inc. for his webinar presentation 

Copy of PV Postcards 2023 (3)

Modern Dermatology Labs: Essential Techniques for Today’s Veterinary Practice

Key insights from Dr. Robert Schick’s recent webinar on small animal dermatology diagnostics.*

Veterinary dermatology has evolved dramatically over the past four decades, and so have our diagnostic tools. In a recent webinar, Dr. Robert Schick, DVM, DACVD, shares critical insights on what’s changed—and what remains essential—in dermatology laboratory techniques. Just as modern cars require different tools than classic vehicles, today’s dermatology cases demand both traditional skills and cutting-edge technology. 

The Modern Approach: Dr. Schick's Philosophy

Dr. Schick demonstrates that modern veterinary dermatology isn’t about choosing between old and new—it’s about strategically combining time-tested techniques with advanced tools to deliver superior patient care and diagnostic accuracy. 

Success requires: 

  • Mastering fundamentals while embracing innovation 
  • Prioritizing consistency over perfect technique 
  • Leveraging digital systems to reduce variability 
  • Utilizing point-of-care testing for faster diagnoses 
  • Proper sample handling regardless of testing method 

Skin Scrapings: Dr. Schick's Refined Technique

Despite revolutionary parasiticides like isoxazolines dramatically reducing mite cases, Dr. Schick emphasizes that proper scraping technique remains crucial for accurate diagnosis. 

Essential steps Dr. Schick teaches: 

  • Gently squeeze skin before scraping 
  • Scrape until capillary oozing occurs 
  • Use skin spatulas instead of blades for safety (around $6) 
  • Scan at 4X power initially 

Monitoring treatment success: Dr. Schick explains that understanding mite life stages is key. Finding dead adults after 4 weeks indicates effective treatment, while continued eggs and larvae suggest therapy adjustment is needed. 

Cytology: Dr. Schick's Most Valuable Diagnostic Tool

The Consistency Challenge 
While diff-quick remains the gold standard, Dr. Schick emphasizes that consistency matters more than perfect technique. 

Common pitfalls Dr. Schick identifies: 

  • Using frosted tape instead of clear tape for preparations 
  • Inconsistent staining protocols 
  • Variable heat-fixing methods 

Ear Cytology vs. Cultures: Why Dr. Schick Chooses Cytology

Dr. Schick strongly advocates for cytology over cultures in ear cases: 

“I have not cultured an ear in so many years I couldn’t even tell you how many.” —Dr. Schick 

Dr. Schick’s reasoning: 

  • External ear cultures are often misleading
  • Sensitivity patterns based on blood levels don’t reflect topical concentrations 
  • Multiple ear sites yield different culture results 
  • Cytology provides immediate, actionable information 

Digital Microscopy Revolution: Dr. Schick Champions The TRUVIEW™ Microscope

The Game Changer for Consistency: Traditional cytology faces a major challenge: technician variability in staining. Dr. Schick demonstrates how Zomedica’s fully automated digital microscope, TRUVIEW™,  solves this problem. 

Benefits Dr. Schick highlights: 

  • Automated, consistent staining with 5-minute processing time 
  • Standardized slide preparation eliminating human error 
  • Superior documentation for medical records 
  • Easy image sharing with clients and referring veterinarians 
  • Remote consultation capabilities 

“This takes all of that variability out,” Dr. Schick notes, highlighting how the system removes human error from the diagnostic process. 

Point-of-Care Revolution: Dr. Schick's TRUFORMA® Platform Success Stories

Dr. Schick showcases how Zomedica’s TRUFORMA® diagnostic platform has transformed in-house diagnostics for dermatology cases: 

Thyroid Testing Breakthrough 

  • Accurate canine TSH levels (previously impossible in-house) 
  • Total T4 and Free T4 testing with 30-minute results vs. overnight shipping 

Adrenal Function Assessment 

  • ACTH measurements for Cushing’s screening 
  • 25-minute results vs. 8-hour dexamethasone suppression tests 

Real case impact: Dr. Schick shares how TRUFORMA diagnosed hypothyroidism in a Cocker Spaniel when the owner’s suspicion proved correct—elevated TSH and unmeasurable T4 confirmed the diagnosis, leading to successful treatment. 

Dermatopathology Excellence: Dr. Schick's Biopsy Guidelines

Dr. Schick emphasizes that proper biopsy technique dramatically impacts diagnostic accuracy: 

Critical Guidelines: 

  • Never scrub lesions before biopsy 
  • Use 6-8mm disposable punches (not 2-4mm) 
  • Handle samples gently at the base 
  • Request dermatopathology-trained pathologists 

Dr. Schick’s Top Mistakes to Avoid:

  1. Reusing disposable punches instead of using fresh ones 
  2. Grabbing biopsy centers with forceps causing tissue damage 
  3. Scrubbing away diagnostic surface material before sampling 
  4. Using inadequate punch sizes that limit diagnostic capability 
  5. Failing to request specialized pathologists for dermatology cases 

Key Takeaways for Modern Practice

Dr. Schick’s comprehensive approach demonstrates that the practices that thrive will be those that maintain diagnostic fundamentals while leveraging technology to overcome traditional limitations like staining variability and lengthy turnaround times. 

Essential points from Dr. Schick’s webinar: 

  • Consistency in technique matters more than perfection 
  • Digital microscopy eliminates human variability in cytology 
  • Point-of-care testing provides immediate, actionable results 
  • Proper biopsy technique is non-negotiable for accurate diagnosis 
  • Modern dermatology combines proven methods with advanced technology 

Dr. Schick’s bottom line: Today’s dermatology diagnostics combine proven techniques with advanced technology. Success comes from mastering fundamentals while strategically embracing innovations that solve real diagnostic challenges. 

Ready to modernize your dermatology diagnostics? Visit Zomedica.com to learn more about TRUVIEW digital microscopy and TRUFORMA point-of-care testing solutions from Zomedica. 

*Dr. Schick was paid by Zomedica, Inc. for his educational webinar.